190 related articles for article (PubMed ID: 9445345)
41. PPBP [4-phenyl-1-(4-phenylbutyl) piperidine] decreases brain injury after transient focal ischemia in rats.
Takahashi H; Kirsch JR; Hashimoto K; London ED; Koehler RC; Traystman RJ
Stroke; 1996 Nov; 27(11):2120-3. PubMed ID: 8898825
[TBL] [Abstract][Full Text] [Related]
42. Neutrophil inhibitory factor treatment of focal cerebral ischemia in the rat.
Jiang N; Chopp M; Chahwala S
Brain Res; 1998 Mar; 788(1-2):25-34. PubMed ID: 9554941
[TBL] [Abstract][Full Text] [Related]
43. A pharmacological analysis of the neuroprotective efficacy of the brain- and cell-permeable calpain inhibitor MDL-28170 in the mouse controlled cortical impact traumatic brain injury model.
Thompson SN; Carrico KM; Mustafa AG; Bains M; Hall ED
J Neurotrauma; 2010 Dec; 27(12):2233-43. PubMed ID: 20874056
[TBL] [Abstract][Full Text] [Related]
44. Gonadal steroids block the calpain-1-dependent intrinsic pathway of apoptosis in an experimental rat stroke model.
Vahidinia Z; Alipour N; Atlasi MA; Naderian H; Beyer C; Azami Tameh A
Neurol Res; 2017 Jan; 39(1):54-64. PubMed ID: 27832728
[TBL] [Abstract][Full Text] [Related]
45. Calpain inhibitor entrapped in liposome rescues ischemic neuronal damage.
Yokota M; Tani E; Tsubuki S; Yamaura I; Nakagaki I; Hori S; Saido TC
Brain Res; 1999 Feb; 819(1-2):8-14. PubMed ID: 10082855
[TBL] [Abstract][Full Text] [Related]
46. Neuroprotective effect of 20(R)-ginsenoside Rg(3) against transient focal cerebral ischemia in rats.
He B; Chen P; Yang J; Yun Y; Zhang X; Yang R; Shen Z
Neurosci Lett; 2012 Sep; 526(2):106-11. PubMed ID: 22925661
[TBL] [Abstract][Full Text] [Related]
47. Long-term neuroprotective effect of inhibiting poly(ADP-ribose) polymerase in rats with middle cerebral artery occlusion using a behavioral assessment.
Ding Y; Zhou Y; Lai Q; Li J; Gordon V; Diaz FG
Brain Res; 2001 Oct; 915(2):210-7. PubMed ID: 11595210
[TBL] [Abstract][Full Text] [Related]
48. Restricted clinical efficacy of cyclosporin A on rat transient middle cerebral artery occlusion.
Matsumoto S; Isshiki A; Watanabe Y; Wieloch T
Life Sci; 2002 Dec; 72(4-5):591-600. PubMed ID: 12467900
[TBL] [Abstract][Full Text] [Related]
49. Depiction of infarct frequency distribution by computer-assisted image mapping in rat brains with middle cerebral artery occlusion. Comparison of photothrombotic and intraluminal suture models.
Zhao W; Ginsberg MD; Prado R; Belayev L
Stroke; 1996 Jun; 27(6):1112-7. PubMed ID: 8650723
[TBL] [Abstract][Full Text] [Related]
50. Neuroprotection with delayed calpain inhibition after transient forebrain ischemia.
Frederick JR; Chen Z; Bevers MB; Ingleton LP; Ma M; Neumar RW
Crit Care Med; 2008 Nov; 36(11 Suppl):S481-5. PubMed ID: 20449914
[TBL] [Abstract][Full Text] [Related]
51. Protection against focal ischemic injury to the brain by trans-sodium crocetinate. Laboratory investigation.
Manabe H; Okonkwo DO; Gainer JL; Clarke RH; Lee KS
J Neurosurg; 2010 Oct; 113(4):802-9. PubMed ID: 19961314
[TBL] [Abstract][Full Text] [Related]
52. Resveratrol attenuates ischemic brain damage in the delayed phase after stroke and induces messenger RNA and protein express for angiogenic factors.
Dong W; Li N; Gao D; Zhen H; Zhang X; Li F
J Vasc Surg; 2008 Sep; 48(3):709-14. PubMed ID: 18572362
[TBL] [Abstract][Full Text] [Related]
53. Calpain activity in the rat brain after transient forebrain ischemia.
Neumar RW; Meng FH; Mills AM; Xu YA; Zhang C; Welsh FA; Siman R
Exp Neurol; 2001 Jul; 170(1):27-35. PubMed ID: 11421581
[TBL] [Abstract][Full Text] [Related]
54. Administration of a competitive NMDA antagonist MDL-100,453 reduces infarct size after permanent middle cerebral artery occlusion in rat.
Jiang N; Zhang RL; Baron BM; Chopp M
J Neurol Sci; 1996 Jun; 138(1-2):36-41. PubMed ID: 8791236
[TBL] [Abstract][Full Text] [Related]
55. Reduction by delayed hypothermia of cerebral infarction following middle cerebral artery occlusion in the rat: a time-course study.
Baker CJ; Onesti ST; Solomon RA
J Neurosurg; 1992 Sep; 77(3):438-44. PubMed ID: 1506891
[TBL] [Abstract][Full Text] [Related]
56. Reduction of infarct size by intra-arterial nimodipine administered at reperfusion in a rat model of partially reversible brain focal ischemia.
Roda JM; Carceller F; Díez-Tejedor E; Avendaño C
Stroke; 1995 Oct; 26(10):1888-92. PubMed ID: 7570744
[TBL] [Abstract][Full Text] [Related]
57. MDL 101,002, a free radical spin trap, is efficacious in permanent and transient focal ischemia models.
Johnson MP; McCarty DR; Velayo NL; Markgraf CG; Chmielewski PA; Ficorilli JV; Cheng HC; Thomas CE
Life Sci; 1998; 63(4):241-53. PubMed ID: 9698033
[TBL] [Abstract][Full Text] [Related]
58. Effectiveness of PSD95 inhibitors in permanent and transient focal ischemia in the rat.
Sun HS; Doucette TA; Liu Y; Fang Y; Teves L; Aarts M; Ryan CL; Bernard PB; Lau A; Forder JP; Salter MW; Wang YT; Tasker RA; Tymianski M
Stroke; 2008 Sep; 39(9):2544-53. PubMed ID: 18617669
[TBL] [Abstract][Full Text] [Related]
59. LC-MS/MS profiling and neuroprotective effects of Mentat® against transient global ischemia and reperfusion-induced brain injury in rats.
Viswanatha GL; Kumar LM; Rafiq M; Kavya KJ; Thippeswamy AH; Yuvaraj HC; Azeemuddin M; Anturlikar SD; Patki PS; Babu UV; Ramakrishnan S
Nutrition; 2015; 31(7-8):1008-17. PubMed ID: 26059376
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of iNOS activity by 1400W decreases glutamate release and ameliorates stroke outcome after experimental ischemia.
Pérez-Asensio FJ; Hurtado O; Burguete MC; Moro MA; Salom JB; Lizasoain I; Torregrosa G; Leza JC; Alborch E; Castillo J; Knowles RG; Lorenzo P
Neurobiol Dis; 2005 Mar; 18(2):375-84. PubMed ID: 15686966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
